Literature DB >> 2745777

Early MR demonstration of spinal metastases in patients with normal radiographs and CT and radionuclide bone scans.

E Avrahami1, R Tadmor, O Dally, H Hadar.   

Abstract

Forty patients with known primary tumor and progressive back pain, suspected of having spinal metastatic disease, underwent magnetic resonance (MR) examinations of the thoracic and lumbosacral spine. Conventional radiographs and CT scans of the spine were all normal. The radionuclide bone scans were equivocal. In 21 patients focal or diffuse vertebral MR abnormalities were detected. In nine patients the lesions were hypointense on T1 sequence, and the same lesions were demonstrated poorly or not at all on T2 and proton density sequences. In eight other patients the bone marrow metastases presented with strong signal intensity on T2 and were poorly or not at all demonstrated on T1 and proton density sequences. In three patients with multiple myeloma, the signal intensity pattern of the vertebrae was diffusely heterogeneous, with alternating small foci of strong and weak signals (a mosaic-like pattern). Following the MR studies, needle biopsy confirmed the malignancy in the 21 patients who had shown abnormalities. No correlation between the type of primary tumor and the signal intensity of the vertebral metastases was shown. Possibly the mosaic pattern shown in three of the multiple myeloma patients represents a special case.

Entities:  

Mesh:

Year:  1989        PMID: 2745777     DOI: 10.1097/00004728-198907000-00008

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  20 in total

1.  Comparison of myelography combined with postmyelographic spinal CT and MRI in suspected metastatic disease of the spinal canal.

Authors:  S Helweg-Larsen; A Wagner; L Kjaer; A Johnsen; J Boesen; T Palner; P S Sørensen
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

Review 2.  Magnetic resonance imaging in rheumatology.

Authors:  C W Heron
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 3.  Radiological diagnosis of skeletal metastases.

Authors:  V Söderlund
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Which MR imaging sequences are necessary in determining the need for radiation therapy for cord compression? A prospective study.

Authors:  A J Johnson; J Ying; T El Gammal; R D Timmerman; R Y Kim; B Littenberg
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

5.  Finding cancer in primary care outpatients with low back pain: a comparison of diagnostic strategies.

Authors:  J D Joines; R A McNutt; T S Carey; R A Deyo; R Rouhani
Journal:  J Gen Intern Med       Date:  2001-01       Impact factor: 5.128

6.  Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study.

Authors:  Colleen M Costelloe; Vikas Kundra; Jingfei Ma; Beth A Chasen; Eric M Rohren; Roland L Bassett; John E Madewell
Journal:  J Magn Reson Imaging       Date:  2011-10-11       Impact factor: 4.813

7.  MRI of extradural spinal tumours at 0.3 T.

Authors:  M H Li; S Holtås; E M Larsson
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

8.  Whole-body magnetic resonance imaging: a useful additional sequence in paediatric imaging.

Authors:  Eoghan E Laffan; Rachael O'Connor; Stephanie P Ryan; Veronica B Donoghue
Journal:  Pediatr Radiol       Date:  2004-04-24

9.  The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study.

Authors:  B G Haubold-Reuter; S Duewell; B R Schilcher; B Marincek; G K von Schulthess
Journal:  Eur J Nucl Med       Date:  1993-11

10.  Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.

Authors:  Mehmet Halit Yilmaz; Mustafa Ozguroglu; Devrim Mert; Hande Turna; Gökhan Demir; Ibrahim Adaletli; Sila Ulus; Metin Halac; Kaya Kanberoğlu
Journal:  Med Oncol       Date:  2007-11-27       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.